Rituximab in the treatment of adult acquired hemophilia A: A systematic review
- 1 July 2007
- journal article
- research article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 63 (1) , 47-52
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Rituximab, an Anti-CD20 Monoclonal Antibody: History and Mechanism of ActionAmerican Journal of Transplantation, 2006
- Acquired hemophilia A: A concise reviewAmerican Journal of Hematology, 2005
- Rituximab for chronic recurring thrombotic thrombocytopenic purpura: a case report and review of the literatureBritish Journal of Haematology, 2004
- Efficacy and safety of rituximab in type II mixed cryoglobulinemiaBlood, 2003
- An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximabAnnals of Oncology, 2003
- Rituximab for the treatment of refractory autoimmune hemolytic anemia in childrenBlood, 2003
- An open study of B lymphocyte depletion in systemic lupus erythematosusArthritis & Rheumatism, 2002
- Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletionAnnals of the Rheumatic Diseases, 2002
- Successful treatment of refractory autoimmune haemolytic anaemia in a post-unrelated bone marrow transplant paediatric patient with rituximabBone Marrow Transplantation, 2002
- Favourable response to therapy with the anti‐CD20 monoclonal antibody rituximab in primary chronic cold agglutinin diseaseBritish Journal of Haematology, 2001